[Diabetic complication].
Iwamoto
Y
Y
Division of Endocrinology and Metabolism, Jichi Medical School.
D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy*; D003929:Diabetic Neuropathies / Q000188:drug therapy*; D006031:Glycosylation; D006801:Humans; D007294:Inositol / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D012236:Rhodanine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D013012:Sorbitol / Q000378:metabolism; D053778:Thiazolidines
D000806:Angiotensin-Converting Enzyme Inhibitors; D011506:Proteins; D053778:Thiazolidines; C038131:epalrestat; D007294:Inositol; D013012:Sorbitol; D012236:Rhodanine; D000449:Aldehyde Reductase